In vitro bone formation using muscle-derived cells: A new paradigm for bone tissue engineering using polymer-bone morphogenetic protein matrices

Biochemical and Biophysical Research Communications

Volumn 305, Issue 4, 2003, Pages 882-889

  Lu, Helen H ^a   Kofron, Michelle D ^b   El Amin, Saadiq F ^c   Attawia, Mohammed A ^e   Laurencin, Cato T ^b,d  

^a Columbia University ^*  (United States)

^b University of Virginia   (United States)

^c UNIVERSITY OF VIRGINIA   (United States)

^d University of Virginia   (United States)

^e Synthes Technical Center   (United States)

Author keywords

Bone morphogenetic protein; Muscle; Poly(lactide co glycolide); Tissue engineering

Indexed keywords

OSTEOGENIC PROTEIN 1; POLYMER;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BONE DEVELOPMENT; BONE MINERALIZATION; CELL ADHESION; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; EVALUATION; NONHUMAN; OSSIFICATION; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION; RABBIT; SKELETAL MUSCLE; TISSUE ENGINEERING;

ORYCTOLAGUS CUNICULUS;

EID: 0037904918     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-291X(03)00858-1     Document Type: Article

References (49)

1. Langer R., Vacanti J.P. Tissue engineering. Science. 260:1993;920-926.
2. Laurencin C.T., Ambrosio A.M.A., Borden M.D., Cooper J.A. Tissue engineering: orthopedic applications. Ann. Rev. Biomed. Eng. 1:1999;19-46.
3. Stevenson S. Biology of bone grafts. Orthop. Clin. North Am. 30:1999;543-552.
4. Yaszemski M.J., Payne R.G., Hayes W.C., Langer R., Mikos A.G. Evolution of bone transplantation: molecular, cellular and tissue strategies to engineer human bone. [Review] [74 refs] Biomaterials. 17:1996;175-185.
5. Freed L.E.et al. Neocartilage formation in vitro and in vivo using cells cultured on synthetic biodegradable polymers. J. Biomed. Mater. Res. 27:1993;11-23.
6. Ishaug-Riley S.L., Crane-Kruger G.M., Yaszemski M.J., Mikos A.G. Three-dimensional culture of rat calvarial osteoblasts in porous biodegradable polymers. Biomaterials. 19:1998;1405-1412.
7. Langer R. 1994 Whitaker lecture: polymers for drug delivery and tissue engineering. Ann. Biomed. Eng. 23:1995;101-111.
8. Mooney D.J., Baldwin D.F., Suh N.P., Vacanti J.P., Langer R. Novel approach to fabricate porous sponges of poly(D,L-lactic-co-glycolic acid) without the use of organic solvents. Biomaterials. 17:1996;1417-1422.
9. Vacanti J.P.et al. Selective cell transplantation using bioabsorbable artificial polymers as matrices. J. Pediatr. Surg. 23:1988;1-9.
10. Leenslag J.W., Pennings A.J., Bos R.R., Rozema F.R., Boering G. Resorbable materials of poly(L-lactide). VII. In vivo and in vitro degradation. Biomaterials. 8:1987;311-314.
11. Leenslag J.W., Pennings A.J., Bos R.R., Rozema F.R., Boering G. Resorbable materials of poly(L-lactide). VI. Plates and screws for internal fracture fixation. Biomaterials. 8:1987;70-73.
12. Matsusue Y.et al. In vitro and in vivo studies on bioabsorbable ultra-high-strength poly(L-lactide) rods. J. Biomed. Mater. Res. 26:1992;1553-1567.
13. Fini M.et al. Resorbable device for fracture fixation: in vivo degradation and mechanical behaviour. Int. J. Artif. Organs. 18:1995;772-776.
14. Lin F.H., Chen T.M., Lin C.P., Lee C.J. The merit of sintered PDLLA/TCP composites in management of bone fracture internal fixation. Artif. Organs. 23:1999;186-194.
15. Elgendy H.M., Norman M.E., Keaton A.R., Laurencin C.T. Osteoblast-like cell (MC3T3-E1) proliferation on bioerodible polymers: an approach towards the development of a bone-bioerodible polymer composite material. Biomaterials. 14:1993;263-269.
16. Yamaguchi A.et al. Recombinant human bone morphogenetic protein-2 stimulates osteoblastic maturation and inhibits myogenic differentiation in vitro. J. Cell Biol. 113:1991;681-687.
17. Ono Y., Kato K., Oohira A., Katoh R., Nogami H. Cell function during chondrogenesis and osteogenesis induced by bone morphogenetic protein enclosed in diffusion chamber. Biochemical studies on native products derived from outside differentiating cells. Clin. Orthop. 1994;305-312.
18. Urist M.R. Bone: formation by autoinduction. Science. 150:1965;893-899.
19. Wang E.A.et al. Recombinant human bone morphogenetic protein induces bone formation. Proc. Natl. Acad. Sci. USA. 87:1990;2220-2224.
20. Celeste A.J.et al. Identification of transforming growth factor β family members present in bone-inductive protein purified from bovine bone. Proc. Natl. Acad. Sci. USA. 87:1990;9843-9847.
21. Zegzula H.D., Buck D.C., Brekke J., Wozney J.M., Hollinger J.O. Bone formation with use of rhBMP-2 (recombinant human bone morphogenetic protein-2). J. Bone Joint Surg. Am. 79:1997;1778-1790.
22. Wozney J.M.et al. Novel regulators of bone formation: molecular clones and activities. Science. 242:1988;1528-1534.
23. Nogami H., Urist M.R. Transmembrane bone matrix gelatin-induced differentiation of bone. Calcif. Tissue Res. 19:1975;153-163.
24. Boyan B.D.et al. Potential of porous poly-D,L-lactide-co-glycolide particles as a carrier for recombinant human bone morphogenetic protein-2 during osteoinduction in vivo. J. Biomed. Mater. Res. 46:1999;51-59.
25. Hollinger J.O., Leong K. Poly(α-hydroxy acids): carriers for bone morphogenetic proteins. Biomaterials. 17:1996;187-194.
26. Kawai T.et al. Osteoinductive activity of composites of bone morphogenetic protein and pure titanium. Clin. Orthop. 1993;296-305.
27. Lieberman J.R.et al. The effect of regional gene therapy with bone morphogenetic protein-2-producing bone-marrow cells on the repair of segmental femoral defects in rats. J. Bone Joint Surg. Am. 81:1999;905-917.
28. Lucas P.A.et al. Ectopic induction of cartilage and bone by water-soluble proteins from bovine bone using a polyanhydride delivery vehicle. J. Biomed. Mater. Res. 24:1990;901-911.
29. Laurencin C.T., Attawia M.A., Borden M.D., Lu H.H., Lieberman J.R. Poly(lactide-co-glycolide)/hydroxyapatite delivery of BMP-2-producing cells: a regional gene therapy approach to bone regeneration. Biomaterials. 2000.
30. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the folin phenol reagent. J. Biol. Chem. 1951;265-275.
31. Jacobs C.R.et al. Differential effect of steady versus oscillating flow on bone cells. J. Biomech. 31:1998;969-976.
32. Kingsley D.M. The TGF-β superfamily: new members, new receptors, and new genetic tests of function in different organisms. Genes Dev. 8:1994;133-146.
33. Reddi A.H. Bone morphogenetic proteins: an unconventional approach to isolation of first mammalian morphogens. Cytokine Growth Factor Rev. 8:1997;11-20.
34. Reddi A.H., Cunningham N.S. Initiation and promotion of bone differentiation by bone morphogenetic proteins. J. Bone Miner. Res. 8(Suppl. 2):1993;S499-S502.
35. Wolf G. Function of the bone protein osteocalcin: definitive evidence. Nutr. Rev. 54:1996;332-333.
36. Stringa E., Filanti C., Giunciuglio D., Albini A., Manduca P. Osteoblastic cells from rat long bone. I. Characterization of their differentiation in culture. Bone. 16:1995;663-670.
37. Lian J.B., Gundberg C.M. Osteocalcin. Biochemical considerations and clinical applications. Clin. Orthop. 1988;267-291.
38. Krebsbach P.H., Gu K., Franceschi R.T., Rutherford R.B. Gene therapy-directed osteogenesis: BMP-7-transduced human fibroblasts form bone in vivo. Hum. Gene Ther. 11:2000;1201-1210.
39. Day C.S.et al. Use of muscle cells to mediate gene transfer to the bone defect. Tissue Eng. 5:1999;119-125.
40. Chaudhari A., Ron E., Rethman M.P. Recombinant human bone morphogenetic protein-2 stimulates differentiation in primary cultures of fetal rat calvarial osteoblasts. Mol. Cell. Biochem. 167:1997;31-39.
41. Denker A.E., Haas A.R., Nicoll S.B., Tuan R.S. Chondrogenic differentiation of murine C3H10T1/2 multipotential mesenchymal cells: I. Stimulation by bone morphogenetic protein-2 in high-density micromass cultures. Differentiation. 64:1999;67-76.
42. Musgrave D.S.et al. The effect of bone morphogenetic protein-2 expression on the early fate of skeletal muscle-derived cells. Bone. 28:2001;499-506.
43. Katagiri T.et al. Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage. J. Cell Biol. 127:1994;1755-1766.
44. Katagiri T.et al. Bone morphogenetic protein-2 inhibits terminal differentiation of myogenic cells by suppressing the transcriptional activity of MyoD and myogenin. Exp. Cell Res. 230:1997;342-351.
45. Jortikka L., Laitinen M., Lindholm T.S., Marttinen A. Internalization and intracellular processing of bone morphogenetic protein (BMP) in rat skeletal muscle myoblasts (L6). Cell. Signal. 9:1997;47-51.
46. Okubo Y., Bessho K., Fujimura K., Iizuka T., Miyatake S. Expression of bone morphogenetic protein-2 via adenoviral vector in C2C12 myoblasts induces differentiation into the osteoblast lineage. Biochem. Biophys. Res. Commun. 262:1999;739-743.
47. Lee J.Y.et al. Enhancement of bone healing based on ex vivo gene therapy using human muscle-derived cells expressing bone morphogenetic protein 2. Hum. Gene Ther. 13:2002;1201-1211.
48. Agrawal C.M., Ray R.B. Biodegradable polymeric scaffolds for musculoskeletal tissue engineering. J. Biomed. Mater. Res. 55:2001;141-150.
49. Winn S.R., Uludag H., Hollinger J.O. Carrier systems for bone morphogenetic proteins. Clin. Orthopaed. Related Res. 367S:1999;S95-S106.